Francesco
Buoso

Equity Partner
Don’t be impressed by money, followers, degrees and titles. Be impressed by kindness, integrity, humility and generosity. Richard Feynman

Francesco is mainly dedicated to advising clients operating in the industrial and commercial sectors, both in their extraordinary transactions (such as M&A, investment transactions, corporate reorganizations, joint ventures) and in their ordinary operations.

In particular, he has gained experience in the biomedical, manufacturing, construction, engineering, energy and trade sectors, assisting both Italian and foreign clients in the preparation and negotiation of their commercial contracts and in the management of their pre-litigation disputes.

In addition to assisting listed companies as well as those with a narrow shareholder base, his work with private business groups has enabled him to develop over time a deep knowledge in the organization and structuring of private or family assets.

Francesco joined the Firm in March 2024.

Previously, he has gained relevant experience at the notary firm of Professor Piergaetano Marchetti, and almost 20 years of experience in the M&A/corporate department of leading law firms, such as Lombardi, Molinari, Segni (now BonelliErede with Lombardi) and Gattai, Minoli, Partners (now PedersoliGattai).

  • Legal 500 2026

    Key Lawyer for Commercial, Corporate and M&A and Private Equity

Commercial and corporate M&A – Private Equity

You might also be interested in

09.10.2026
LCA advises the selling shareholders on the sale of Planta to SIS

The transaction strengthens the maize genetics platform of the BF group’s seed division

05.10.2026
LCA alongside Impresoft in the acquisition of Marketplace Generation and Addiction ...

The group controlled by Clessidra Private Equity strengthens its e-commerce and MarTech offering  

01.10.2026
LCA Studio Legale strengthens the Corporate M&A practice with the arrival of ...

The firm consolidates the practice in extraordinary transactions and in advising Italian and U.S. investors  

25.09.2026
LCA advises the sellers on the sale of 60% of Ecupharma to Adamed Group

Majority stake sold in the Italian pharmaceutical company active in neurology, psychiatry, urology and diabetology

21.09.2026